findmyKOL
Clinical trialNCT06686043RecruitingPhase 2Interventional

HPV Vaccine, Imiquimod, and Metformin Combination Trial

SponsorBaylor College of MedicineEnrollment85Cervical CarcinomaHPV (Human Papillomavirus)-Associated CarcinomaVaginal CarcinomaVulvar Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center

    Houston, Texas, United States

    Jan S Sunde, MD
    Not, yet, recruiting
  • Harris Health Smith Clinic

    Houston, Texas, United States

    Jan S Sunde, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Aug 2024
Primary completion
23 Aug 2026
Completion
23 Aug 2028
Last update posted
13 Nov 2024
Registered enrollment
85
Registry id
NCT06686043
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.